September 26, 2014
The Health Service Bureau’s Specific Disease Control Division notified prefectural health authorities on September 19 that daclatasvir/asunaprevir combination therapy for chronic hepatitis C and type C compensated cirrhosis has been added to the list of treatments eligible for medical subsidies...read more